Contribute Try STAT+ Today

The top spokesperson for the drug industry’s main lobbying group in Washington is taking a job at the oil giant ExxonMobil, STAT has confirmed.

Robert Zirkelbach, who most recently served as executive vice president of public affairs at PhRMA, has been the organization’s top communicator since 2016. Zirkelbach has developed a reputation as a fierce defender of industry, oftentimes publicly sparring with drug pricing activists and rival industry groups in person and on Twitter, but he has also played a central role in the organization’s efforts to rebrand itself as a voice for scientists toiling in labs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Not sure the desire to lower drug prices especially on high-end drugs has ended completely. Maybe slowed down because of other issues. Could come back however if new Covid-19 therapeutics and vaccines come in on the high side.

Comments are closed.